January 2022 in “Przegla̧d dermatologiczny” This article reviews potential causes of frontal fibrosing alopecia but does not provide new clinical findings.
January 2022 in “Przegla̧d dermatologiczny” This article reviews various treatment options for diseases associated with cicatricial alopecia but reports no new clinical results.
December 2020 in “Journal of Face Aesthetics” This study found that trichoscopy, a non-invasive diagnostic method, may effectively differentiate between types of focal alopecia in the parietal area in adult women, indicating specific trichoscopic features for conditions like alopecia areata, discoid lupus erythematosus, and lichen planopilaris.
November 2020 in “Postepy Dermatologii I Alergologii” This review discusses the potential of using SULT1A1 expression in the scalp as a biomarker to predict response to minoxidil treatment for androgenetic alopecia, but reports no new clinical results.
March 2026 in “Berkala Ilmu Kesehatan Kulit dan Kelamin” In this observational study of medical students at the University of Muhammadiyah North Sumatra, no significant link was found between wearing headscarves and experiencing hair loss.
March 2024 in “Authorea (Authorea)” This retrospective case series reports on the use of STRAVIX PL, a shelf-stable human umbilical tissue allograft, in managing recurrent pilonidal cyst wounds, suggesting potential benefits in reducing recurrence and providing durable wound coverage compared to traditional methods.
December 2024 in “Journal of Education Health and Sport” This study explored how excessive sugar consumption detrimentally affects skin health by promoting processes like glycation and inflammation, concluding that a low-glycemic index diet could help prevent and manage skin conditions such as acne and psoriasis.
January 2025 in “Advances in Dermatology and Allergology” This literature review conducted a comprehensive analysis of existing studies on micro-needling mesotherapy in dermatology and aims to offer a practical guide for its clinical application, though it provides no new experimental findings.
January 2025 in “Dermatology Review” This literature review reports significant advancements in dermatology from January 2018 to March 2024, highlighting progress in skin cancer detection, biologic therapies, wound healing, and pediatric dermatology, reflecting an evolving field that enhances clinical practice and patient care.
June 2023 in “Journal of Education, Health and Sport” This study reviewed existing evidence and concluded that while CBD is an effective treatment for certain epilepsy syndromes, more research is required to establish its safety and effectiveness for conditions like anxiety and Parkinson’s disease, and clinicians should monitor ongoing trial results.
18 citations
,
January 2013 in “Postepy Dermatologii I Alergologii” This article discusses the common dermatological issues in adolescence linked to hormone fluctuations, such as acne and excessive sweating, and reports no new clinical results.
10 citations
,
November 2017 in “Advances in Dermatology and Allergology” This study found that scalp involvement in pemphigus is linked to greater disease severity and longer times to achieve both clinical and serological remission, suggesting it may require more aggressive treatment.
3 citations
,
May 2019 in “Ginekologia Polska” This study found that adolescents with abnormal uterine bleeding are more likely to have secondary amenorrhea, PCOS, and higher rates of insulin resistance compared to healthy peers.
9 citations
,
January 2019 in “Postepy Dermatologii I Alergologii” The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.
1 citations
,
December 2024 in “Pomeranian Journal of Life Sciences” This review found that microneedling can stimulate various biological pathways to promote tissue remodeling, enhance skin regeneration, and benefit conditions like wound healing and skin rejuvenation, with emerging uses in targeted drug delivery and periodontal therapy.
1 citations
,
April 2019 in “Endokrynologia Polska” This review discusses lifestyle interventions to manage weight and reduce metabolic consequences in women with PCOS but reports no new clinical results, highlighting the need for more randomized studies.
February 2024 in “Journal of Education, Health and Sport” This study reviews literature indicating that certain drugs used to treat dermatological conditions, such as retinoids and glucocorticoids, may rarely cause psychiatric symptoms like depression and anxiety, which are more commonly observed in patients with skin disorders compared to the general population.
January 2026 in “Forum Dermatologicum” This review analyzed scientific literature and found that dermatological symptoms, such as hirsutism and acne, frequently appear as early indicators of PCOS, reflecting hormonal imbalances and aiding diagnosis of the disorder.
January 2026 in “Forum Dermatologicum” This study systematically reviewed literature on paradoxical reactions during biologic treatments for psoriasis, identifying immune dysregulation mechanisms and diverse clinical manifestations, highlighting that mild cases often respond well to topical treatments, while severe cases may require switching to different IL-23 inhibitors.
January 2015 in “Dermatology Review” This study found that LED light therapy may stimulate skin regeneration and wound healing, with various wavelengths affecting fibroblast proliferation, collagen synthesis, and hair growth in experimental settings.
15 citations
,
April 2022 in “Ginekologia Polska” Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.
January 2018 in “Przegla̧d dermatologiczny” This research review discusses the potential link between androgenetic alopecia and increased cardiovascular risk but does not report any new experimental findings.
March 2025 in “Journal of Education Health and Sport” This review, drawing on scientific literature, explores alopecia areata's pathogenesis and treatment, noting that while therapies like JAK inhibitors show promise, there remains a significant need for more effective and targeted solutions, and a better understanding of the disease mechanisms.
January 2026 in “Quality in Sport” This review observed that semaglutide may have therapeutic benefits for skin conditions like psoriasis and hidradenitis suppurativa, but reports of adverse skin reactions exist, indicating the need for further research to understand its safety and efficacy in dermatology.
August 2025 in “Endokrynologia Polska” A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.
March 2024 in “Jagiellonian University Repository (Jagiellonian University)” This study found that DNA methylation-based age predictors and lifestyle factors significantly affect perceived age and external visible characteristics in the aging process, with implications for forensic and anti-aging cosmetic applications.
89 citations
,
March 1996 in “Proceedings of the National Academy of Sciences” This study found that homozygous mutant mice with a hypomorphic CD18 mutation developed a chronic inflammatory skin disease resembling human psoriasis, potentially implicating additional genetic factors in disease susceptibility.
August 2024 in “Quality in Sport” This study highlights the challenges faced by women with PCOS and emphasizes the importance of lifestyle changes, such as diet and weight loss, as the primary treatment strategy to manage symptoms and reduce associated health risks.
11 citations
,
December 2022 in “Arterial Hypertension” This joint position paper by several Polish medical societies examines guidelines and recommendations for managing conditions like obesity, hypertension, and liver disease, underscoring the importance of a collaborative, interdisciplinary approach in treatment. Results are not explicitly reported.
5 citations
,
December 2021 in “Pediatric investigation” In this study, children with 5-alpha-reductase deficiency and micropenis treated with oral testosterone undecanoate showed increased penile length to a target level after 3-9 months, with no severe adverse effects observed, suggesting the treatment's safety and efficacy.